Methenamine Hippurate
Drug - Methenamine Hippurate
The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Methenamine Hippurate
Multiple ingredients are in alphabetical order.
Strength -
1GM
The potency of the active ingredient(s), Methenamine Hippurate. May repeat for multiple part products.
Applicant -
COREPHARMA
The firm name holding legal responsibility for Methenamine Hippurate. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
076411
The FDA assigned number to Methenamine Hippurate. Format is nnnnnn.
Product Number -
001
The FDA assigned number to identify Methenamine Hippurate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Jun 20, 2003
The date Methenamine Hippurate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
No
The pioneer or innovator of Methenamine Hippurate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
RX
The group or category of approved drugs Methenamine Hippurate is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Corepharma Llc
The full name of the firm holding legal responsibility for the new application of Methenamine Hippurate.
Methenamine Hippurate
|
